|
|
|
Volumn 311, Issue 7010, 1995, Pages 899-909
|
|
Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
BUSULFAN;
CHLORMETHINE;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTOTOXIC AGENT;
DOXORUBICIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
LOMUSTINE;
METHOTREXATE;
MITOMYCIN C;
NITROSOUREA;
PREDNISOLONE;
PROCARBAZINE;
TEGAFUR;
UFT;
VINBLASTINE;
VINCA ALKALOID;
VINCRISTINE;
VINDESINE;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
META ANALYSIS;
PATIENT CARE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RISK;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
COMBINED MODALITY THERAPY;
HUMANS;
LUNG NEOPLASMS;
PROPORTIONAL HAZARDS MODELS;
RANDOMIZED CONTROLLED TRIALS;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
|
EID: 0028843552
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3036)
|
|
References (67)
|
